Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-15 · accession 0001438133-23-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-17 | 2023-05-15 | TNDM | Morrison Susan | EVP, Chief Admin. Off | F - Tax | $32.13 | -586 | 11.6K | -5% | -$18.8K |
| DM | 2023-05-17 | 2023-05-15 | TNDM | Morrison Susan | EVP, Chief Admin. Off | M - OptEx | $0.00 | +2,060 | 11.6K | +21% | $0 |
| D | 2023-05-17 | 2023-05-15 | TNDM | Morrison Susan | EVP, Chief Admin. Off | A - Grant | $27.32 | +633 | 11.5K | +6% | +$17.3K |
| DM | 2023-05-17 | 2023-05-15 | TNDM | Morrison Susan | EVP, Chief Admin. Off | M - OptEx | $0.00 | -2,060 | 3,794 | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-15 | F | D | 539 | $32.13 | 12,958 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-15 | M | A | 1,897 | $0.00 | 13,497 | D | — | — | |
| 3 | Common | Common Stock | 2023-05-15 | F | D | 47 | $32.13 | 11,600 | D | — | — | |
| 4 | Common | Common Stock | 2023-05-15 | M | A | 163 | $0.00 | 11,647 | D | — | — | |
| 5 | Common | Common Stock | 2023-05-15 | A | A | 633 | $27.32 | 11,484 | D | — | — | (F1) The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c). |
| 6 | Derivative | Restricted Stock Unit | 2023-05-15 | M | D | 163 | $0.00 | 1,299 | D | — · — to — | 163 Common Stock | (F3) Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). (F4) RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. |
| 7 | Derivative | Restricted Stock Unit | 2023-05-15 | M | D | 1,897 | $0.00 | 3,794 | D | — · — to — | 1,897 Common Stock | (F3) Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). (F5) RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. |